
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.960 | 4.960 | 0.000 |
Shares | 95.040 | 95.040 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.680 | 18.048 |
Price to Book | 3.175 | 3.312 |
Price to Sales | 1.733 | 2.206 |
Price to Cash Flow | 13.286 | 13.535 |
Dividend Yield | 3.059 | 2.927 |
5 Years Earnings Growth | 7.049 | 9.084 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 33.780 | 30.832 |
Financial Services | 20.440 | 21.604 |
Consumer Defensive | 16.650 | 12.771 |
Industrials | 11.380 | 15.773 |
Consumer Cyclical | 8.600 | 5.335 |
Basic Materials | 6.210 | 8.188 |
Technology | 2.940 | 3.408 |
Number of long holdings: 51
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 9.04 | 101.16 | -0.37% | |
Nestle | CH0038863350 | 8.96 | 75.39 | +0.65% | |
Roche Holding Participation | CH0012032048 | 8.28 | 260.30 | -0.27% | |
Richemont | CH0210483332 | 5.41 | 139.75 | -1.06% | |
Zurich Insurance Group | CH0011075394 | 4.75 | 584.40 | +0.83% | |
Alcon | CH0432492467 | 3.16 | 63.66 | -0.16% | |
UBS Group | CH0244767585 | 3.14 | 32.38 | -0.61% | |
Givaudan | CH0010645932 | 2.77 | 3,370.00 | -0.33% | |
Partners Group | CH0024608827 | 2.47 | 1,097.50 | -1.57% | |
Lonza Group | CH0013841017 | 2.42 | 567.00 | -0.46% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SIHong Kong Equity C CHF Acc | 7.42B | 2.54 | -3.58 | 1.56 | ||
SIAsian Equity Yield C CHF Acc | 956.75M | 3.55 | 6.15 | 4.97 | ||
SISwiss Small Mid Cap Equity C Acc | 136.47M | 14.24 | 4.59 | 6.47 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review